Shotlee LogoShotlee
Blog
Download on theApp Store
Get it onGoogle Play
Skip to main content
How Restaurants Are Adapting to Rising GLP-1 Usage Like Ozempic - Featured image
GLP-1 Medications

How Restaurants Are Adapting to Rising GLP-1 Usage Like Ozempic

Shotlee Editorial Team
Written by Shotlee Editorial TeamHealth Research & Writing
·February 13, 2026·5 min read

On this page

  • The Rise of GLP-1 Drugs and Their Impact on Dining Out
  • Cuba Libre's Pioneering GLP-1 Menu: A Case Study
  • Business Strategy: Opportunity Over Risk
  • Practical Guidance for GLP-1 Users Dining Out
  • Industry-Wide Trends and Future Outlook
  • Key Takeaways for Patients and Restaurants
  • Conclusion: A New Era of Mindful Dining
  • The Origin Story Behind the Menu
  • Sample Dishes and Nutritional Design
  • Safety Considerations with GLP-1 Drugs

Track Smart

Calculate active GLP-1 levels automatically with Shotlee.

Download →

Popular GLP-1 drugs like Ozempic and Wegovy are curbing appetites, prompting restaurants to adapt with specialized menus. Cuba Libre's Barry Gutin explains their high-protein, smaller-portion offerings designed with a doctor's input. This trend signals a lasting change in dining habits.

Share

On this page

  • The Rise of GLP-1 Drugs and Their Impact on Dining Out
  • Cuba Libre's Pioneering GLP-1 Menu: A Case Study
  • Business Strategy: Opportunity Over Risk
  • Practical Guidance for GLP-1 Users Dining Out
  • Industry-Wide Trends and Future Outlook
  • Key Takeaways for Patients and Restaurants
  • Conclusion: A New Era of Mindful Dining
  • The Origin Story Behind the Menu
  • Sample Dishes and Nutritional Design
  • Safety Considerations with GLP-1 Drugs

GLP-1 medications such as Ozempic and Wegovy are transforming eating habits across America, with reduced appetites and cravings for sweets and alcohol. Restaurants are responding by tailoring menus to accommodate these changes, ensuring diners on these drugs can enjoy balanced, nutrient-dense meals without waste or discomfort. This adaptation highlights a broader shift in the culinary landscape driven by the growing popularity of GLP-1 therapies for weight management and metabolic health.

The Rise of GLP-1 Drugs and Their Impact on Dining Out

GLP-1 receptor agonists like Ozempic (semaglutide) and Wegovy work by mimicking the glucagon-like peptide-1 hormone, which regulates blood sugar, slows gastric emptying, and signals fullness to the brain. This mechanism significantly suppresses appetite, often leading users to consume smaller portions and prioritize nutrient quality over quantity. For patients, this means dining out requires options that are visually appealing, flavorful, and packed with protein and fiber to prevent issues like muscle loss or gastrointestinal upset.

Clinically, maintaining muscle mass is crucial during weight loss on GLP-1 drugs, as rapid fat reduction without adequate protein can lead to sarcopenia. High-fiber foods support gut health, which is vital since these medications can cause nausea or constipation. Restaurants ignoring these needs risk losing GLP-1 users—and their dining companions—who may veto establishments lacking suitable choices.

Cuba Libre's Pioneering GLP-1 Menu: A Case Study

Leading the charge is Barry Gutin, co-founder of the Cuba Libre Restaurant and Rum Bar chain on the East Coast. Gutin recently introduced a dedicated menu for people on GLP-1 medications, recognizing the drugs' profound effects on eating patterns.

"I think it's not a fad," Gutin said. "I think it's a significant shift in the way people are eating. And, you know, there's a great deal of obesity in the U.S. and other countries, and these drugs are becoming more popular, easier to get, less expensive. They're moving from injectables to pills. So I see it gaining steam."

The Origin Story Behind the Menu

The idea sparked from real diner feedback. "Actually, two friends of mine at different tables on the same night were on GLP-1 drugs and were teaching me how they have to eat. And one had suggested, 'Why don't you have a special menu for us?' I thought it was a good idea," Gutin recounted.

These friends emphasized more than just smaller appetites: meals must look and smell enticing to overcome suppressed hunger, while delivering essential nutrients. Gutin collaborated with Dr. Charlie Seltzer, a Philadelphia-based weight loss specialist, to develop five dishes featuring high protein, high fiber, moderate to low fat, and moderate to low calories in smaller portions—at reduced prices to match.

Sample Dishes and Nutritional Design

Every dish minimizes carbohydrates to prioritize protein and fiber, preventing users from filling up on empty calories like rice or pasta. A standout is the beef dish ropa vieja, a traditional Cuban braised, shredded, and stewed beef brisket with tomatoes, bell peppers, onions, a reduced portion of rice and beans, and asparagus. The menu also includes chicken, salmon, and shrimp options, all with listed nutritional facts: calories, fat, fiber, carbohydrates, and protein.

  • High protein: Supports muscle preservation during GLP-1-induced weight loss.
  • High fiber: Aids digestion and satiety.
  • Moderate/low fat and calories: Aligns with smaller appetites.
  • Smaller portions/prices: Reduces waste and cost.

Business Strategy: Opportunity Over Risk

Gutin views this as an opportunity, not a risk, despite potential revenue dips from less food and alcohol consumption. "If we can super-serve these guests and they have a group of people, we may gain that group of people because the GLP-1 diner knows that he can get what he needs there," he explained.

Precision tracking for your journey

Join thousands using Shotlee to accurately track GLP-1 medications and side effects.

📱 Get the Shotlee App

Track your GLP-1 medications, peptides, and health metrics on the go with our mobile app!

Download on theApp Store
Get it onGoogle Play

The strategy extends beyond GLP-1 users. Cuba Libre tested "Lighter portions, lighter prices, nutritionally balanced" sections on main dinner menus in Philadelphia and Washington, D.C., incorporating three unchanged GLP-1 dishes. Results? About 25% of ropa vieja sales come from the lighter portions category, attracting health-conscious diners regardless of medication status.

Practical Guidance for GLP-1 Users Dining Out

For those on Ozempic, Wegovy, or similar GLP-1 therapies, seek restaurants offering customizable or nutrient-focused options. Prioritize protein-rich entrees (aim for 20-30g per meal), fiber from vegetables, and minimal refined carbs. Discuss portion sizes with servers and start with appetizers if full meals overwhelm.

Consult your doctor about nutritional needs, especially if experiencing side effects like nausea. Tools like Shotlee can help track symptoms, side effects, and medication-aligned meal logs for better management. Always balance GLP-1 use with resistance training and monitoring for deficiencies in vitamins or electrolytes.

Safety Considerations with GLP-1 Drugs

While effective for weight loss and metabolic health, GLP-1s carry risks like gastrointestinal issues, dehydration, or pancreatitis. Smaller, balanced meals mitigate these by easing digestion. Compared to alternatives like older weight loss drugs (e.g., phentermine), GLP-1s offer superior cardiovascular benefits but require vigilant nutrition.

Industry-Wide Trends and Future Outlook

Cuba Libre's move reflects a growing trend. As GLP-1 prescriptions surge—fueled by pills like oral semaglutide—more chains may follow with "GLP-1 friendly" labels. This caters to obesity epidemics while appealing to wellness trends like intermittent fasting or low-carb diets.

Non-GLP-1 diners benefit too, as lighter options promote mindful eating. Gutin's approach ensures inclusivity: GLP-1 users dine with friends ordering full portions, avoiding vetoes.

Key Takeaways for Patients and Restaurants

  • GLP-1 drugs like Ozempic reduce appetite, necessitating high-protein, fiber-rich, smaller meals.
  • Cuba Libre's menu, developed with Dr. Charlie Seltzer, exemplifies adaptation with dishes like ropa vieja.
  • Business wins: 25% lighter portion sales show broad appeal.
  • Patients: Look for nutritional transparency; track intake for optimal health.
  • Trend: Expect more restaurants prioritizing balanced, affordable smaller plates.

Conclusion: A New Era of Mindful Dining

Restaurants adapting to GLP-1 usage signal a cultural shift toward sustainable eating amid obesity challenges. Stories like Barry Gutin's at Cuba Libre empower users to dine confidently. Patients should partner with healthcare providers, explore these menus, and leverage apps for tracking to maximize benefits. This evolution benefits everyone pursuing metabolic health.

This interview was edited for clarity. Samantha Raphelson produced and edited this interview for broadcast with Michael Scotto. Scotto also produced it for the web. Originally published on WBUR.org.

Source Information

Originally published by KOSU.Read the original article →

Read next

Keep exploring

More on Ozempic

Articles covering Ozempic dosing, side effects, and clinical updates.

This Is Your Home on GLP-1 Medications
Health & Lifestyle

This Is Your Home on GLP-1 Medications

As GLP-1 drugs reshape American life, they are sparking a behind-the-scenes transformation of our homes, from med-station bathrooms to ghost-town kitchens.

10 min read
Montana Brown Shows Off Her Incredible Post-Baby Body Transformation Amidst Ozempic Accusations
Health & Wellness

Montana Brown Shows Off Her Incredible Post-Baby Body Transformation Amidst Ozempic Accusations

Reality star Montana Brown denies using GLP-1 injections for postpartum weight loss, citing fitness instead. Medical experts discuss the implications of celebrity health claims and safe weight management practices.

8 min read
FDA Peptide Panel's Recommendations and the Future of Dietary Supplements
Health & Wellness

FDA Peptide Panel's Recommendations and the Future of Dietary Supplements

A recent FDA advisory committee meeting delved into the regulatory future of several peptides, sparking debate about their eligibility for pharmacy compounding and their potential role in the dietary supplement market. This article examines the committee's recommendations, the FDA's stance, and what this means for consumers and the industry.

7 min read

Same topic: Restaurant Adaptations

All Restaurant Adaptations articles →
Ozempic Users Reshape How America Dines Out
GLP-1 Medications

Ozempic Users Reshape How America Dines Out

The rise of Ozempic and similar GLP-1 medications is dramatically altering dining out habits across America, with users ordering less food and leaving meals uneaten. Restaurants face revenue pressures as customers skip courses and reduce alcohol intake. Forward-thinking spots are introducing smaller portions and tapas-style menus to adapt.

4 min read
GLP-1 Drugs Like Ozempic Rewriting Denver Restaurant Menus?
GLP-1 Medications

GLP-1 Drugs Like Ozempic Rewriting Denver Restaurant Menus?

GLP-1 weight-loss drugs weren't meant to change restaurant menus, but they're doing just that in Denver and beyond. With appetites reset by Ozempic and similar meds, spots like Olive & Finch are prioritizing protein-packed small plates over supersized servings. Here's how the GLP-1 era is reshaping everyday eating.

5 min read

More in GLP-1 Medications

Tapatío: Secret Weapon Against GLP-1 Induced Taste Loss?
GLP-1 Medications

Tapatío: Secret Weapon Against GLP-1 Induced Taste Loss?

Tapatío hot sauce, a Southern California favorite, is gaining traction among GLP-1 users battling taste loss from drugs like Ozempic and Wegovy. Private equity firm Highlander Partners acquired the brand to capitalize on this trend, as spicy heat invigorates dulled taste buds. Experts explain the science behind GLP-1 taste changes and offer hope for recovery.

6 min read
Ozempic Fuels Tapatío Hot Sauce Boom: L.A. Icon's Story
GLP-1 Medications

Ozempic Fuels Tapatío Hot Sauce Boom: L.A. Icon's Story

Ozempic isn't just transforming waistlines—it's igniting a surge in hot sauce sales like Tapatío's. As millions embrace GLP-1 drugs, cravings for bold flavors skyrocket, propelling L.A.'s iconic brand into national expansion under new owners Highlander Partners. This is the untold story of family legacy meeting metabolic health trends.

5 min read
Super Bowl LX Ads Feature AI, GLP-1 Drugs & Celebs from Clooney to Jenner
GLP-1 Medications

Super Bowl LX Ads Feature AI, GLP-1 Drugs & Celebs from Clooney to Jenner

Super Bowl LX is set to showcase a surge in GLP-1 weight-loss drug ads from telehealth giants like Ro featuring Serena Williams and Novo Nordisk's Ozempic and Wegovy. With record $8-10M ad slots, health trends dominate alongside AI and celebrity-packed spots with George Clooney and Kendall Jenner. This 'GLP-1 Super Bowl' highlights booming demand for metabolic health solutions.

6 min read
Share this article
  1. Home
  2. Blog
  3. How Restaurants Are Adapting to Rising GLP-1 Usage Like Ozempic
Shotlee Editorial Team — Health Research & Writing
Written by

Shotlee Editorial Team

Health Research & Writing

Shotlee’s guides and articles are researched and written in-house by the Shotlee Editorial Team. We build every page from primary sources — FDA labels, official prescribing information, and peer-reviewed clinical trials — and cite them directly. Our content is educational and is not a substitute for advice from your own healthcare provider.

View all articles by Shotlee Editorial Team
Shotlee LogoShotlee

Your comprehensive health tracking companion. Track, analyze, and optimize your journey with advanced metrics and community support.

Product

  • Medication Trackers
  • Health Guides
  • Calculators
  • Syringe Calculator
  • Compare Medications
  • Pricing

Resources

  • Health Blog
  • Support Center

Legal

  • Privacy Policy
  • Terms of Service
  • Community Guidelines
  • Refund Policy

© 2026 Shotlee. All rights reserved.

Made with for the community♥ for the community